Fox Run Management L.L.C. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 87,573 shares of the construction company’s stock, valued at approximately $1,040,000. Fox Run Management L.L.C. owned about 0.11% of Aspen Aerogels as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. KLP Kapitalforvaltning AS acquired a new stake in Aspen Aerogels during the fourth quarter worth about $164,000. Quantbot Technologies LP purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth about $768,000. Palogic Value Management L.P. acquired a new stake in Aspen Aerogels during the 4th quarter worth approximately $1,544,000. Intech Investment Management LLC raised its holdings in Aspen Aerogels by 57.4% in the fourth quarter. Intech Investment Management LLC now owns 28,267 shares of the construction company’s stock valued at $336,000 after buying an additional 10,311 shares during the period. Finally, Commonwealth Equity Services LLC lifted its position in Aspen Aerogels by 45.9% during the fourth quarter. Commonwealth Equity Services LLC now owns 22,192 shares of the construction company’s stock valued at $264,000 after buying an additional 6,982 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.
Aspen Aerogels Trading Up 1.8 %
NYSE ASPN opened at $7.06 on Friday. The company’s fifty day moving average price is $9.61 and its two-hundred day moving average price is $15.32. The company has a market capitalization of $578.93 million, a price-to-earnings ratio of 44.10 and a beta of 2.28. Aspen Aerogels, Inc. has a 12 month low of $6.60 and a 12 month high of $33.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on ASPN. Craig Hallum dropped their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. B. Riley decreased their target price on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. TD Cowen raised shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Finally, Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus target price of $19.11.
Get Our Latest Analysis on Aspen Aerogels
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
See Also
- Five stocks we like better than Aspen Aerogels
- Short Selling: How to Short a Stock
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is the Nasdaq? Complete Overview with History
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Canada Bond Market Holiday: How to Invest and Trade
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.